381 studies found for:    diabetes and type 1 and open and active | Open Studies
Show Display Options
Rank Status Study
1 Unknown  The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.
Condition: Type 1 Diabetes
Interventions: Behavioral: Intensive Physical activity;   Behavioral: Control- regular physical activity
2 Recruiting Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control
Conditions: Closed Loop;   Diabetes Mellitus, Type 1
Interventions: Device: Diabeloop System;   Device: Continuous Glucose Monitoring;   Device: Accelerometer and heart rate monitor;   Dietary Supplement: Meals
3 Recruiting A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin glargine (U300) HOE901;   Drug: Insulin glargine HOE901;   Drug: Insulin glulisine HMR1964;   Drug: Insulin aspart;   Drug: Insulin lispro
4 Recruiting Evaluation of Automated Insulin Pump Settings Using the MD-Logic Advise4U
Condition: Type 1 Diabetes
Interventions: Device: MD-Logic Pump Advisor;   Other: Control Group
5 Not yet recruiting Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 6-day intervention with sensor-augmented pump therapy;   Other: 6-day intervention with single-hormone closed-loop strategy;   Other: 6-day intervention with dual-hormone closed-loop strategy;   Drug: Insulin;   Drug: Glucagon;   Device: Continuous Glucose Monitoring System Enlite sensor®, Medtronic;   Device: Insulin pump MiniMed® Paradigm® Veo™, Medtronic
6 Not yet recruiting Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 5-day intervention with single-hormone closed-loop strategy;   Other: 5-day intervention with sensor-augmented pump therapy;   Other: 5-day intervention with dual-hormone closed-loop strategy;   Device: Insulin pump;   Device: Continuous glucose monitoring system;   Drug: Insulin;   Drug: Glucagon
7 Recruiting Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
Condition: Diabetes Mellitus Type 1
Interventions: Drug: Sitagliptin;   Drug: Exercise
8 Not yet recruiting An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Exenatide;   Drug: Albiglutide
9 Recruiting Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Device: MD- Logic Closed Loop System;   Device: sensor augmented pump therapy
10 Recruiting At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation
Condition: Type 1 Diabetes Mellitus
Interventions: Device: CGM and Insulin Pump;   Device: Closed-Loop Control System
11 Recruiting Home Testing of Day and Night Closed Loop With Pump Suspend Feature
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Endocrine System Diseases;   Autoimmune Diseases
Interventions: Other: FlorenceM;   Other: Medtronic insulin pump 640G
12 Unknown  Closing the Loop in Young Children With Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Procedure: Overnight closed-loop insulin delivery
13 Recruiting Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Device: Patient's insulin pump;   Drug: Insulin;   Device: Dexcom G4 Platinum glucose sensor;   Other: Single-hormone closed-loop
14 Unknown  A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Drug: HM11260C;   Drug: Placebo;   Drug: Victoza
15 Recruiting Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy
Condition: Diabetes Mellitus, Type I
Interventions: Device: Dexcom G4 Platinum CGM system;   Device: Dexcom G4 Platinum CGM system with Share
16 Not yet recruiting Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients
Condition: Type I Diabetes
Interventions: Biological: Wockhardt's Insulin Analogue (Recomb);   Biological: Lantus®
17 Recruiting Physical Activity and Glycemic Control in Adolescents
Condition: Type 1 Diabetes
Interventions: Behavioral: Reinforcement for meeting targeted physical activity goals;   Other: Standard of Care
18 Recruiting A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin, Onglyza;   Drug: Dapagliflozin, Farxiga;   Drug: Glargine insulin;   Drug: Metformin XR
19 Not yet recruiting Bright 1 Bodies Weight Management Program
Condition: Diabetes Mellitus, Type 1
Intervention: Behavioral: Bright 1 Bodies
20 Recruiting Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living Conditions
Condition: Type 1 Diabetes
Interventions: Device: Florence D2A or similar closed loop glucose control system;   Device: CSII with CGM

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years